302
V. Martínez Cornejo et al. / Journal of Organometallic Chemistry 799-800 (2015) 299e310
2014/7 [44]. The PF6 anion in all compounds, the CH2Cl2 solvent in
compound 1b and the arene ring in compounds 2b and 2d are
disordered and were refined in two major contributors and refined
anisotropically.
The solution was passed through a short column of Al2O3 using
CH2Cl2 as an eluent. A pale yellow fraction was collected and
evaporated to dryness. Crystallization from CH2Cl2/diethyl ether
(slow diffusion) gave yellow crystals, which were washed with
diethyl ether and dried under vacuum.
2.3. General procedure for complexes 1
2.4.1. Synthesis of 2a
In a typical experiment, a solution of 1d (200 mg, 0.40 mmol)
and 0.6 mmol of the ligand (1a triphenylphosphine, 1b tri-n-
butylphosphine or 1c triphenylstibine) in 30 mL of MeOH was
stirred for 20 h at 45 ꢀC. The solvent was evaporated under vacuum,
and the residue was dissolved in CH2Cl2. The solution was passed
through a short column of Al2O3 using CH2Cl2 as an eluent. A pale
yellow fraction was collected and evaporated to dryness. Crystal-
lization from CH2Cl2/diethyl ether (slow diffusion) gave yellow
crystals, which were washed with diethyl ether and dried under
vacuum.
2.4.1.1. Yield. 341 mg, 85%. 1H NMR (CD3COCD3): 9.26 (d, 1H,
3JHH ¼ 5.5, H8), 7.81 (d, 1H, 3JHH ¼ 7.5, H1), 7.53 (t, 1H, 3JHH ¼ 7.7 Hz,
3
H2), 7.47e7.38 (m, 2H, H3 and H6), 7.32 (dd, 3H, JHH ¼ 7.9 Hz,
4JHH ¼ 6.1 Hz, H4, H5 and H7), 7.25e7.14 (m, 6H, PPh3), 7.01e6.77
(m, 9H, PPh3), 6.03 (s, 6H, C6H6). 31P{1H} NMR (CD3COCD3): 43.84
(s, PPh3), ꢃ144.19 (stp, 1JPF ¼ 707.8 Hz, PF6). M/S FABþ: 596 [(M þ H)
e PF6] (82%), 518 [(M þ H) e (C6H6 þ PF6)] (38%), 334 [(M þ H) e
(PPh3 þ PF6)] (18%), 256 [(M þ H) e (C6H6 þ PPh3 þ PF6)] (8%). IR
(FTIR): y 832 (PF6, s). Anal.: Calcd.: C35H29F6NP2Ru$CH2Cl2: C, 52.38,
H, 3.78; N, 1.70. Found: C, 52.98; H, 3.82; N ¼ 1.83.1
2.3.1. Synthesis of 1a
2.4.2. Synthesis of 2b
2.3.1.1. Yield. 202 mg, 70%. 1H NMR (CD3CN): 8.04 (d, 1H,
3JHH ¼ 8 Hz, H1), 7.61e7.30 (m, 15H, PPh3), 7.16 (t, 1H, 3JHH ¼ 7.2 Hz,
H2), 6.98 (t, 1H, 3JHH ¼ 7 Hz, H3), 6.63 (d, 1H, 3JHH ¼ 7.5, H4), 5.60 (s,
6H, C6H6), 2.91 (s, 3H, NMe), 2.71 (s, 3H, NMe), 2.72 (d, 1H,
2JHH ¼ 14 Hz, H5), 2.39 (d, 1H, 2JHH ¼ 14, Hz, 2H, H6). 31P{1H} NMR
2.4.2.1. Yield. 368 mg, 70%. 1H NMR (CD3COCD3): 9.23 (d,
3JHH ¼ 5.8 Hz, 1H, H8), 8.18 (d, 1H, 3JHH ¼ 8.1 Hz, H1), 8.06e7.91 (m,
3H, H2, H3 and H6), 7.26 (t, 1H, 3JHH ¼ 7.3 Hz, H4), 7.21e7.12 (m, 2H,
H5 and H7), 6.16 (s, 6H, C6H6), 1.53e1.11 (m, 18H, PBu3), 0.8 (t,
3J ¼ 7.0 Hz, 9H, PBu3). 31P{1H} NMR (CD3COCD3): 21.39 (s,
PBu3): ꢃ144 (stp, J ¼ 706.6 PF6). M/S FABþ: 536 ([M þ H] e PF6]:
(100%), 458 [(M þ H) e (C6H6 þ PF6)] (28%), 334 [(M þ H) e
(PBu3 þ PF6)] (18%), 256 [(M þ H) e (C6H6 þ PBu3 þ PF6)] (19%). IR
1
(CD3CN): 33.5 (s, PPh3), ꢃ144.6 (stp, JPF ¼ 704.25 Hz, PF6). M/S
FABþ: 576 [(M þ H) e PF6] (18%), 498 [(M þ H) e (C6H6 þ PF6)]
(12%), 314 [(M þ H) e (PPh3 þ PF6)] (15%), 236 [(M þ H) e
(C6H6 þ PPh3 þ PF6)] (6%). IR (FTIR):
y 832 (PF6, s). Anal. Calcd. for
(FTIR):
y 832 (PF6, s). Anal. Calcd. for C29H41F6NP2Ru: C, 51.17; H,
C
33H33F6NP2Ru: C, 55.00; H, 4.62; N, 1.94. Found: C, 54.72; H, 4.65;
6.07; N, 2.06. Found: C, 51.26; H, 5.91; N, 2.08.
N, 2.12.
2.4.3. Synthesis of 2c
2.3.2. Synthesis of 1b
2.3.2.1. Yield. 184 mg, 70%. 1H NMR (CD3CN): 7.79 (d, 1H,
3JHH ¼ 9 Hz, H1), 7.11e6.85 (m, 3H, H2þH3þH4), 5.76 (s, 6H, C6H6),
3.59 (d, 1H, 2JHH ¼ 12 Hz, H5), 3.31 (d, 1H, 2JHH ¼ 12 Hz, H6), 2.93 (s,
3H, NMe), 2.74 (s, 3H, NMe), 1.84e1.53 (m, 6H, PBu3), 1.43e1.20 (m,
12H, PBu3), 0.90 (t, 3JHH ¼ 6.8 Hz, 9H, PBu3). 31P{1H} NMR (CD3CN):
2.4.3.1. Yield. 397 mg, 88%. 1H NMR (CD3CN) 9.0 (d, 1H, 3JHH ¼ 6 Hz,
3
H8), 7.83 (d, 1H, JHH ¼ Hz, H1), 7.56e7.35 (m, 6H, H2 to H7),
7.30e7.25 (m, 6H, SbPh3), 7.05e6.9 (m, 9H, SbPh3), 5.90 (s, 6H,
C6H6). 31P{1H} NMR (CD3CN): ꢃ143.99 (stp, 1JPF ¼ 704.25 PF6). M/S
FABþ: 687 [(M þ H) e PF6] (35%), 609 [(M þ H) e (C6H6 e PF6)] (1%),
13.02 (s, PBu3), ꢃ144 (stp, JPF ¼ 704.6 Hz, PF6). M/S FABþ: 516
1
334 [(M
þ
H)
e
(SbPh3
e
PF6)] (92%), 256 [(M
830 (PF6, s). Anal. Calcd. for
35H29F6NPRuSb$0.5CH2Cl2: C, 48.79; H, 3.46; N, 1.60. Found: C,
þ
H) e
[(M þ H) e PF6] (100%), 438 [(M þ H) e (C6H6 þ PF6)] (34%), 314
(C6H6 þ SbPh3 þ PF6)] (25%). IR (FTIR):
y
[(M
þ
H)
e
(PBu3
þ
PF6)] (96%), 236 [(M
þ
H) e
C
(C6H6 þ PBu3 þ PF6)] (30%). IR (FTIR):
y 831 (PF6, s). Anal. Calcd. for
48.77; H, 3.47; N, 1.67.
C
27H45F6NP2Ru$0.5CH2Cl2: C, 46.98; H, 6.59; N, 1.99. Found: C,
47.41; H, 6.51; N, 2.21.
2.5. Synthesis of 2d
2.3.3. Synthesis of 1c
A solution of complex 3′ (200 mg, 0.543 mmol) and AgPF6
(137.4 mg, 0.543 mmol) in 25 mL of acetonitrile was stirred for 2 h
at room temperature. The reaction mixture was filtered through
Celite and the remaining pale yellow solution was evaporated to
dryness. Crystallization from CH2Cl2/diethyl ether (slow diffusion)
gave yellow crystals, which were washed with diethyl ether and
dried under vacuum. Yield: 197 mg, 70%. 1H NMR (CD3CN): 9.24
2.3.3.1. Yield. 275 mg, 85%. 1H NMR (CD3CN): 8.05 (d, 1H,
3JHH ¼ 6 Hz, H1), 7.53 (t, 3H, JHH ¼ 7.5 Hz, H9), 7.44 (t, 6H,
3
3JHH ¼ 7 Hz, H9), 7.32 (d, 6H, JHH ¼ 7.5 Hz, H9), 7.16 (t, 1H,
3
3JHH ¼ 7.5 Hz, H2), 6.96 (t, 1H, JHH ¼ 7.5 Hz, H3), 6.69 (d, 1H,
3
3JHH ¼ 7 Hz, H4), 5.79 (s, 6H, C6H6), 3.17 (d, 1H, JHH ¼ 15 Hz, H5),
2
3.04 (s, 3H, NMe), 2.93 (d, 1H, 3JHH ¼ 12 Hz, H6), 2.74 (s, 3H, NMe).
31P{1H} NMR (CD3CN): ꢃ144 (stp, 1JPF ¼ 706.5 Hz, PF6). M/S FABþ:
667 [(M þ H) e PF6] (12%), 589 [(M þ H) e (C6H6 þ PF6)] (2%), 314
3
4
3
(dd, 1H, JHH ¼ 6 Hz, JHH ¼ 2 Hz, H8), 8.17 (ddd, 1H, JHH ¼ 8 Hz,
5
4JHH ¼ 1.5, JHH ¼ 0.6 Hz, H1), 7.94e7.90 (m, 2H, H3 and H5), 7.77
(dd,1H, 3JHH ¼ 8 Hz, 4JHH ¼ 1.5 Hz, H7), 7.28e7.15 (m, 3H, H2, H4 and
H6), 5.78 (s, 6H, C6H6), 2.16 (s, 3H, NCMe). 31P{1H} NMR
(CD3CN): ꢃ144 (stp, 1JPF ¼ 704.25 Hz, PF6). M/S FABþ: 375[(M þ H)
e PF6] (1%), 297 [(M þ H) e (C6H6 þ PF6)] (2%), 334 [(M þ H) e
(NCMe þ PF6)] (32%), 256 [(M þ H) e (C6H6 þ NCMe þ PF6)] (8%). IR
[(M
(C6H6 þ SbPh3 þ PF6)] (10%). IR (FTIR):
33H33F6NPRuSb: C, 48.85; H, 4.10; N, 1.73; Found: C, 48.83; H, 4.10;
N, 1.87.
þ
H)
e
(SbPh3
þ
PF6)] (45%), 236 [(M
þ
H) e
y
831 (PF6, s). Anal.: Calcd. for
C
2.4. General procedure for complexes 2aec
(FTIR):
y 827 (PF6, s), 2261 (NCMe, w). Anal. Calcd. for
C19H17F6N2PRu: C, 43.94; H, 3.30; N, 5.39. Found: C, 43.83; H, 3.22;
N, 5.30.
In a typical experiment, a solution of 3’ (200 mg, 0.543 mmol),
0.815 mmol of ligand (2a triphenylphosphine, 2b tri-n-butylphos-
phine or 2c triphenylstibine) and NH4PF6 (177 mg, 1.086 mmol) in
30 mL of MeOH was stirred for 20 h at 45 ꢀC. The solvent was
evaporated under vacuum, and the residue was dissolved in CH2Cl2.
1
Although these results are outside the range viewed as establishing analytical
purity, they are provided to illustrate the best values obtained to date.